newsfilter
← Latest News
Business Wire·

TYME Announces Abstract Selected for Publication at the 2021 American Society of Clinical Oncology Annual Meeting

TYME Technologies, Inc. (NASDAQ:TYME) (the "Company" or "Tyme"), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that its abstract featuring data from the Company's investigational therapy, SM-8